Miami, Florida, USA
The cell and gene therapy session highlights curative programs targeting single-gene defects such as haemophilia, muscular dystrophy, and immunodeficiencies. These therapies are targeting the underlying genetic defect rather than the management of symptoms—moving from long-term management toward long-term correction and functional recovery.